Document is current

Article History

Received: 1 June 2023

Revised: 7 October 2023

Accepted: 12 October 2023

First Online: 1 November 2023

Declarations

:

: This study adhered to the tenets of the Declaration of Helsinki, and the Centro de Ojos Quilmes ethics committee approved the design of this study. Informed consent was obtained from every patient before starting the treatment: the participating patients previously signed an informed consent form, explaining that a drug would be used off-label, that their data would be evaluated for scientific research purposes, and that the results would be published in academic fields while protecting their identity.

: The authors approved the final manuscript for submission.

: The authors declare no competing interests.